| Literature DB >> 27574317 |
Chunsheng Li1, Christine Bartizel2, Paolo Battisti3, Axel Böttger4, Céline Bouvier5, Antonio Capote-Cuellar6, Zhanat Carr7, Derek Hammond8, Martina Hartmann9, Tarja Heikkinen10, Robert L Jones11, Eunjoo Kim12, Raymond Ko1, Roberto Koga13, Boris Kukhta14, Lorna Mitchell15, Ryan Morhard16, Francois Paquet5, Debora Quayle1, Petr Rulik17, Baki Sadi1, Aleksanin Sergei18, Inmaculada Sierra19, Wanderson de Oliveira Sousa20, Gyula Szab21.
Abstract
The Global Health Security Initiative (GHSI) established a laboratory network within the GHSI community to develop collective surge capacity for radionuclide bioassay in response to a radiological or nuclear emergency as a means of enhancing response capability, health outcomes and community resilience. GHSI partners conducted an exercise in collaboration with the WHO Radiation Emergency Medical Preparedness and Assistance Network and the IAEA Response and Assistance Network, to test the participating laboratories (18) for their capabilities in in vitro assay of biological samples, using a urine sample spiked with multiple high-risk radionuclides (90Sr, 106Ru, 137Cs, and 239Pu). Laboratories were required to submit their reports within 72 h following receipt of the sample, using a pre-formatted template, on the procedures, methods and techniques used to identify and quantify the radionuclides in the sample, as well as the bioassay results with a 95% confidence interval. All of the participating laboratories identified and measured all or some of the radionuclides in the sample. However, gaps were identified in both the procedures used to assay multiple radionuclides in one sample, as well as in the methods or techniques used to assay specific radionuclides in urine. Two-third of the participating laboratories had difficulties in determining all the radionuclides in the sample. Results from this exercise indicate that challenges remain with respect to ensuring that results are delivered in a timely, consistent and reliable manner to support medical interventions. Laboratories within the networks are encouraged to work together to develop and maintain collective capabilities and capacity for emergency bioassay, which is an important component of radiation emergency response.Entities:
Mesh:
Substances:
Year: 2017 PMID: 27574317 PMCID: PMC5723924 DOI: 10.1093/rpd/ncw254
Source DB: PubMed Journal: Radiat Prot Dosimetry ISSN: 0144-8420 Impact factor: 0.972